Business context and reporting period
Glucotrack, Inc. filed this Form 8-K for events beginning September 22, 2026; the report was signed September 28, 2026. The filing concerns amendments to warrants and convertible notes issued in connection with prior financings.
Key financial and capital structure information
- The company stated that outstanding senior secured Bridge Notes were repaid in full on September 25, 2026, in connection with the closing of a registered direct offering. The filing does not provide the repayment amount or offering proceeds.
- The filing provides no revenue, profit, cash flow, margin, or liquidity figures.
Material changes to financing terms
- Amendments to Bridge Warrants, Common Warrants issued in an August private placement, and September Warrants remove provisions allowing downward adjustment to the applicable Floor Price.
- September Note amendments also make the Floor Price an absolute minimum for conversion and Conversion Price adjustments, and require any True-Up Amount under the make-whole provision to be paid only in cash.
- September Note amendments became effective September 28, 2026, after execution by the company and all holders. Warrant amendments became effective upon execution and delivery by the company and each applicable holder; execution of Bridge Warrant amendments was still ongoing when reported.
Outlook, risks, and items to verify
The filing gives no guidance or management outlook. The amendments change conversion, anti-dilution, and payment terms; their potential effects on dilution and cash requirements are not quantified.
- Verify the final number of Bridge Warrant amendments executed and which holders are covered.
- Review the filed amendment exhibits for the complete revised terms and applicable Floor Prices.
- Verify the registered direct offering proceeds and the amount and source of the Bridge Note repayment.
- Assess potential dilution from outstanding notes and warrants, and cash exposure from any True-Up Amounts.